Jason Winkler, Executive Vice President and CFO, Motorola Solutions to Participate in the UBS Global Technology and AI Conference

Motorola Solutions (NYSE: MSI), a global leader in public safety and enterprise security, today announced that Jason Winkler, Executive Vice President and Chief Financial Officer, will participate at the upcoming UBS Global Technology and AI Conference on Monday, December 1, 2025 at 4:55 p.m. MST.

A live webcast and replay of the session will be featured on Motorola Solutions' Investor Relations website at https://www.motorolasolutions.com/investors/events-and-presentations.html .

About Motorola Solutions | Solving for safer

Safety and security are at the heart of everything we do at Motorola Solutions. We build and connect technologies to help protect people, property and places. Our solutions foster the collaboration that's critical for safer communities, safer schools, safer hospitals, safer businesses, and ultimately, safer nations. Learn more about our commitment to innovating for a safer future for us all at www.motorolasolutions.com .

Investor Contact
Tim Yocum
Motorola Solutions
tim.yocum@motorolasolutions.com
+1 847-576-6899

News Provided by Business Wire via QuoteMedia

MSI
The Conversation (0)
NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs

NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs

COMPUTEX -- NVIDIA today announced new NVIDIA RTX ™ technology to power AI assistants and digital humans running on new GeForce RTX ™ AI laptops. NVIDIA unveiled Project G-Assist — an RTX-powered AI assistant technology demo that provides context-aware help for PC games and apps. The Project... Keep Reading...
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO

Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO

Studies presented represent key focus areas, including building evidence for clinical utility of comprehensive genomic profiling; overcoming market access barriers, and progressing the whole-genome approach for MRD Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based... Keep Reading...
Merck Announces First-Quarter 2023 Financial Results

Merck Announces First-Quarter 2023 Financial Results

First Quarter 2023 Reflected Continued Strong Underlying Performance Across Key Growth Drivers, Particularly in Oncology and Vaccines Total Worldwide Sales Were $14.5 Billion, a Decrease of 9% From First Quarter 2022; Excluding LAGEVRIO, Growth Was 11%; Excluding LAGEVRIO and the Impact of... Keep Reading...

Latest Press Releases

Related News